Cite
APA Citation
Tran, H., Brighton, T., Grigg, A., McRae, S., Dixon, J., Thurley, D., Gandhi, M. K., Truman, M., Marlton, P., & Catalano, J. (n.d.). a multi‐centre, single‐arm, open‐label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R‐ITP1000 study). British journal of haematology, 167, 243–251. http://access.bl.uk/ark:/81055/vdc_100025054315.0x000017